1Rivera J, Lozano ML, Navarro-N/Jfiez L, et al. Platelet recep- tors and signaling in the dynamics of thrombus formation[J]. Haematologica, 2009,94 (5) : 700-711. 被引量：1
2Yusuf S, Zhao F, Mehta SIR, et al. Effects of clopidogrel in ad- dition to aspirin in patients with acute coronary syndromes without ST-segment elevation [J ]. N Engl J Med, 2001,345 (7) : 494-502. 被引量：1
3Abergel E, Nikolsky E. Ticagrelor: an investigational oral an- tiplatelet treatment for reduction of major adverse cardiac e- vents in patients with acute coronary syndrome [J ]. Vasc Health Risk Manag,2010 ,6:963 -977. 被引量：1
5Teng R, Oliver S, Hayes MA, et al. Absorption, distribution, metabolism, and excretion of ticagrelor in healthy subjects[J].Drug Metab Dispos,2010 ,38(9):1514-21. 被引量：1
9Zhou D, Andersson TB, Grimm SW. In vitro evaluation of po- tential drug-drug interactions with ticagrelor: cytochrome P450 reaction phenotyping, inhibition, induction, and differential ki- neties[J]. Drug Metab Dispos, 2011 , 39 (4) : 703-10. 被引量：1
10Storey RF, Angiolillo DJ, Patil SB, el al. Inhibitory effects ofticagrelor compared with clopidogrel on platelet function in pa- tients with acute coronary syndromes:the PLATO (PI.ATelet inhibition and patient Outcomes)PLATELET substudy[J]. J Am Coil Cardiol,2010 ,56(18) : 1456- 62. 被引量：1
